Clinical Trial Update: Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update involving Astragalus Membranaceus for aneurysmal subarachnoid hemorrhage across Phase 2 and Phase 3, status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Astragalus membranaceus (Astragalus membranaceus)

Snippet

Sponsor: China Medical University Hospital | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2, Phase 3 | Status: UNKNOWN